Ancon Medical appears in Kent Online in UK

Dr Boris Gorbunov
Dr. Boris Gorbunov

Dr. Boris Gorbunov of Ancon was recently interviewed by Kent Online and Kentish Gazette Newspaper in the UK over the new NBT technology.

Article below:

Boffins in Canterbury say they have developed a cancer-detecting breath test machine that could save millions of lives.

Dr. Boris Gorbunov is director and lead scientist of Ancon Medical, the company behind the breakthrough after ten years of work.His 12-strong team – based at the Canterbury Innovation Centre – has now built a prototype of the machine that they say could be miniaturised and installed in GP surgeries and hospitals throughout the country and overseas.

They claim it can detect the very earliest stages of a broad range of cancers, long before any symptoms appear.

Dr. Gorbunov, an internationally renowned expert in nanotechnology, said: “While there is existing breath-test technology to detect illnesses, nothing comes near the sensitivity of ours, which we have now patented.

“The impact of our technology would be massive because cancers are our biggest killer, and this has the potential to save thousands of lives a year.

“We believe it is the holy grail of medical diagnosis because it is inexpensive, simple to use, and early diagnosis hugely increases a patient’s chance of survival.”

The technology works by detecting biomarkers in the compound molecules emitted in a person’s breath, which can then be linked to specific types of cancer.

The company is using the same technology to develop a machine that can sample the air to detect explosives or drugs. It is said to be thousands of times more sensitive than a drugs dog’s nose.

Dr. Gorbunov says his firm has the backing to develop that machine from the Ministry of Defence.

He said: “We have got so far with research grants but now need funding to produce around five smaller devices which we can take to health and clinical trial stage.

“Ultimately, we see them as being desktop machines, costing between £15,000 and £20,000, which is a small price to pay for the number of lives they could save and the reduced cost to the health service.”

Search news

Categorized news

Read from archive

Be the first to get our news

NBT Technology Video